TY  - CHAP
M1  - Book, Section
TI  - Anesthesia for Renal Transplantation
A1  - Meinecke, Barbara
A2  - Ellinas, Herodotos
A2  - Matthes, Kai
A2  - Alrayashi, Walid
A2  - Bilge, Aykut
PY  - 2021
T2  - Clinical Pediatric Anesthesiology
AB  - FOCUS  POINTSCongenital  and  structural  abnormalities  are  the  leading  causes  of  pediatric  renal  failure.The  adult  approach,  curvilinear  incision  and  retroperitoneal  placement  of  the  donor  kidney,  is  the  current  surgical  technique.Careful  review  of  preoperative  medications  is  warranted,  especially  angiotensin  converting  enzyme  inhibitors  (ACEIs)  or  angiotensin  II  receptor  blockers  (ARBs)  that  may  affect  cardiac  hemodynamics  intraoperatively.Vascular  access  can  be  a  challenge  and  may  require  a  preoperative  placement  in  the  interventional  radiology  suite  for  successful  placement.Sugammadex  has  been  proven  to  be  safe  and  effective  in  patients  with  renal  failure,  perhaps  with  slower  recovery  compared  with  patients  with  normal  renal  function.  Sugammadex  and  sugammadex-rocuronium  complexes  are  cleared  by  hemodialysis.Providing  optimal  hemodynamics  for  graft  reperfusion  is  extremely  important;  this  goal  can  be  accomplished  with  the  administration  of  crystalloid,  colloid,  blood  products,  and/or  inotropic  infusions.Causes  of  graft  loss  in  the  immediate  postoperative  period  include  primary  nonfunction  of  the  new  organ  and  thrombosis  of  vessels.Malignancy  is  a  potential  complication  after  transplant  surgery  with  post-transplant  lymphoproliferative  disease  (PTLD)  being  the  most  common,  developed  from  latent  Epstein–Barr  virus  (EBV).  
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/19
UR  - accessanesthesiology.mhmedical.com/content.aspx?aid=1176458825
ER  -